Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease

Author： Boulos Alan S.   Agner Celso   Deshaies Eric M.  

Publisher： Maney Publishing

ISSN： 1743-1328

Source： Neurological Research, Vol.27, Iss.7, 2005-10, pp. : 95-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pediatric neurovascular disease, 1st edition

By Mallucci Conor  

Acta Neurochirurgica, Vol. 149, Iss. 3, 2007-03 ,pp. : 330-330

Springer Publishing Company

Access to resources Recommend Favorite

The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H3 Receptor Antagonist in Patients with Mild to Moderate Alzheimer's Disease: A Preliminary Investigation

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 240-251

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development

By Jullienne Amandine   Badaut Jérôme  

Future Neurology, Vol. 8, Iss. 6, 2013-11 ,pp. : 677-689

Future Medicine

Access to resources Recommend Favorite

Three case reports of secondary mania: evidence supporting a right frontotemporal locus

By Gafoor R.   O'Keane V.  

European Psychiatry, Vol. 18, Iss. 1, 2003-02 ,pp. : 32-33

Elsevier

Access to resources Recommend Favorite

Aphasia and auditory extinction: Preliminary evidence of binding

By Shisler Rebecca  

Aphasiology, Vol. 19, Iss. 7, 2005-07 ,pp. : 633-650

Routledge Ltd

Access to resources Recommend Favorite